Uncategorized

FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use – CNBC

Posted on Author Tim Hodges Comments Off on FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use – CNBC
  1. FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use  CNBC
  2. F.D.A. Approves Ozempic to Treat Kidney Disease  The New York Times
  3. US FDA Approves Novo Nordisk’s Diabetes Drug to Reduce Risk of Worsening Kidney Disease  U.S. News & World Report
  4. Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment  The Wall Street Journal
  5. Novo’s Ozempic Notches Approval for Kidney Disease, Widening Use  Bloomberg